Nuvation Bio Valuation
| NUVB Stock | USD 2.88 0.26 9.92% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Nuvation Bio secures a last-minute Real Value of $3.2 per share. The latest price of the firm is $2.88. Our model forecasts the value of Nuvation Bio from analyzing the firm fundamentals such as Operating Margin of (66.16) %, return on equity of -0.96, and Shares Outstanding of 335.57 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Nuvation Bio's valuation include:
Price Book 1.9282 | Enterprise Value 431.4 M | Enterprise Value Ebitda 2.2258 | Price Sales 448.3409 | Enterprise Value Revenue 199.5229 |
Undervalued
Today
Please note that Nuvation Bio's price fluctuation is risky at this time. Calculation of the real value of Nuvation Bio is based on 3 months time horizon. Increasing Nuvation Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Nuvation Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nuvation Stock. However, Nuvation Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.88 | Real 3.2 | Target 4.08 | Hype 2.87 | Naive 2.83 |
The real value of Nuvation Stock, also known as its intrinsic value, is the underlying worth of Nuvation Bio Company, which is reflected in its stock price. It is based on Nuvation Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Nuvation Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Nuvation Bio helps investors to forecast how Nuvation stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nuvation Bio more accurately as focusing exclusively on Nuvation Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Nuvation Bio's intrinsic value based on its ongoing forecasts of Nuvation Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Nuvation Bio's closest peers. If more than one evaluation category is relevant for Nuvation Bio we suggest using both methods to arrive at a better estimate.
Nuvation Bio Cash |
|
Nuvation Valuation Trend
Comparing Nuvation Bio's enterprise value against its market capitalization is a good way to estimate the value of Nuvation Bio uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Nuvation Bio Total Value Analysis
Nuvation Bio is now anticipated to have valuation of 431.37 M with market capitalization of 969.31 M, debt of 4.01 M, and cash on hands of 703.8 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nuvation Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
431.37 M | 969.31 M | 4.01 M | 703.8 M |
Nuvation Bio Asset Utilization
One of the ways to look at asset utilization of Nuvation is to check how much profit was generated for every dollar of assets it reports. Nuvation Bio secures a negative usage of assets of -0.14 %, losing $0.001398 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Nuvation Bio shows how discouraging it operates for each dollar spent on its assets.Nuvation Bio Ownership Allocation
Nuvation Bio maintains a total of 335.57 Million outstanding shares. Nuvation Bio holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Nuvation Bio Profitability Analysis
Net Loss for the year was (75.8 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nuvation Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nuvation Bio and how it compares across the competition.
About Nuvation Bio Valuation
The stock valuation mechanism determines Nuvation Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Nuvation Bio. We calculate exposure to Nuvation Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nuvation Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -222 K | -233.1 K |
Nuvation Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 218.9 M |
Nuvation Bio Current Valuation Indicators
Valuation refers to the process of determining the present value of Nuvation Bio and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Nuvation we look at many different elements of the entity such as Nuvation's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Nuvation Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Nuvation Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Nuvation Bio's worth.Complementary Tools for Nuvation Stock analysis
When running Nuvation Bio's price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |